These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 2883406)
21. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Montanaro A; Pirofsky B Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy. Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277 [TBL] [Abstract][Full Text] [Related]
23. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children. Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612 [TBL] [Abstract][Full Text] [Related]
24. Administration of intravenous immunoglobulin in two children with hypogammaglobulinaemia due to protein losing enteropathy. De Giacomo C; Maggiore G; Scotta MS; Ugazio AG Clin Exp Immunol; 1985 May; 60(2):447-8. PubMed ID: 4006307 [No Abstract] [Full Text] [Related]
25. [Variable immune deficiency syndrome with antibody deficiency--long-term substitution with immunoglobulins]. Vaith P; Maas D Immun Infekt; 1984 Apr; 12(2):123-8. PubMed ID: 6442916 [TBL] [Abstract][Full Text] [Related]
26. IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients. Williams PE; Leen CL; Heppleston AD; Yap PL Blut; 1990 Mar; 60(3):198-201. PubMed ID: 2317569 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of treatment of children with hypogammaglobulinemia: comparison of fresh plasma and intravenous immunoglobulin preparation. Bernatowska E; Weremowicz R; Janowicz W; Madaliński K Arch Immunol Ther Exp (Warsz); 1986; 34(4):377-84. PubMed ID: 3099724 [TBL] [Abstract][Full Text] [Related]
28. Phase I study of intravenous gamma globulin in multiple myeloma. Gordon DS; Hearn EB; Spira TJ; Reimer CB; Phillips DJ; Schable C Am J Med; 1984 Mar; 76(3A):111-6. PubMed ID: 6424442 [TBL] [Abstract][Full Text] [Related]
29. Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemia. So A; Brenner MK; Hill ID; Asherson GL; Webster AD Br Med J (Clin Res Ed); 1984 Nov; 289(6453):1177-8. PubMed ID: 6437475 [TBL] [Abstract][Full Text] [Related]
30. Prophylactic effect of self-administered pump-driven subcutaneous IgG infusion in patients with antibody deficiency: a triple-blind cross-over study comparing P-IgG levels of 3 g l-1 versus 6 g l-1. Remvig L; Andersen V; Hansen NE; Karle H J Intern Med; 1991 Jan; 229(1):73-7. PubMed ID: 1995766 [TBL] [Abstract][Full Text] [Related]
31. Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases. Ersoy F; Tezcan I; Sanal O Turk J Pediatr; 1992; 34(4):203-9. PubMed ID: 1306339 [TBL] [Abstract][Full Text] [Related]
32. Long-term parenteral exposure to mercury in patients with hypogammaglobulinaemia. Haeney MR; Carter GF; Yeoman WB; Thompson RA Br Med J; 1979 Jul; 2(6181):12-4. PubMed ID: 466248 [TBL] [Abstract][Full Text] [Related]
33. Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group. Jolles S; Sánchez-Ramón S; Quinti I; Soler-Palacín P; Agostini C; Florkin B; Couderc LJ; Brodszki N; Jones A; Longhurst H; Warnatz K; Haerynck F; Matucci A; de Vries E Clin Exp Immunol; 2017 Nov; 190(2):226-234. PubMed ID: 28708268 [TBL] [Abstract][Full Text] [Related]
34. Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon. Lockner D; Bratt G; Lindborg A; Törnebohm E Acta Med Scand; 1987; 221(4):413-5. PubMed ID: 3111178 [TBL] [Abstract][Full Text] [Related]
35. Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases. Fischer SH; Ochs HD; Wedgwood RJ; Skvaril F; Morell A; Hill HR; Schiffmann G; Corey L Monogr Allergy; 1988; 23():225-35. PubMed ID: 3386642 [TBL] [Abstract][Full Text] [Related]
36. [Substitution therapy in agammaglobulinemia]. Roord JJ; van der Meer JW Ned Tijdschr Geneeskd; 1983 Aug; 127(32):1417-9. PubMed ID: 6621729 [No Abstract] [Full Text] [Related]
37. Subcutaneous gammaglobulin: effective management of hypogammaglobulinaemia. Bayston K; Leahy MF; McCreanor JD; Gebbie T N Z Med J; 1985 Aug; 98(784):652. PubMed ID: 3861980 [No Abstract] [Full Text] [Related]
38. Sarcoidosis and primary hypogammaglobulinaemia: a report of two cases and a review of the literature. Leen CL; Bath JC; Brettle RP; Yap PL Sarcoidosis; 1985 Sep; 2(2):91-5. PubMed ID: 3939612 [TBL] [Abstract][Full Text] [Related]
39. Intravenous immune globulin therapy. Treatment of a patient with severe immunodeficiency, chronic malabsorption, and fulminant septicemia. Gonzalez EB; Guernsey BG; Ingrim NB; Ichikawa Y; Daniels JC Arch Intern Med; 1985 May; 145(5):945-6. PubMed ID: 3922322 [TBL] [Abstract][Full Text] [Related]
40. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]